Press Releases
Dafra Pharma Press Releases
Other Press Releases
Contact Us
Sitemap
Links
Vacancies
Corporate Profile
Mission
History
Products
Research & Development
Promotional Network
Board of Directors
Financial Profile
Pharmaceutical Products
Finished Products
Malaria Treatments
Branded Generics
Consumer Health Products
API’s
Research & Development
Clinical
Malaria
Other Infectious Diseases
Biosynthetic artemisinin
Board of Directors
CEO:
Bruno Jansen
Medical Director:
Dr FH Jansen (MD, PhD)
Administrative Director:
Luc Verduyckt
French African Sales Director:
Ousmane Macinanke
